Skip to content

Cryoport

US · CYRX #3336 by market cap Listed 2015
17.35 -0.45 -2.53%
Live - 5344 symbols - heartbeat 281s ago · 2026-10-08 09:16
Pre-market 17.19 -0.93%
After-hours 17.35 0.00%
Overnight 17.30 -0.29%
Market cap
878.76M
P/B
1.98
EPS
1.40
Reader sentiment Are you bullish or bearish on CYRX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 4.1 percentage points.

Institutional ownership

Held by institutions
95.64% -4.13pp
Institutions
227 -1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund62.21%
Hedge Fund21.53%
Public Company5.83%
Individual/Insider3.51%
Private Company2.37%
Insurance Company1.22%
Family Office/Trust1.18%
VC/PE Fund0.90%
Government Pension Fund0.41%
Other0.85%

Top holders as of 2026-06-30

BlackRock 8.33% · 4.22M sh
Cadian Capital Management, LP 5.77% · 2.92M sh
Vanguard Capital Management, LLC 4.91% · 2.49M sh
Morgan Stanley 4.44% · 2.25M sh
Millennium Management LLC 3.41% · 1.72M sh
Fred Alger Management, LLC 3.05% · 1.55M sh
Geode Capital Management, LLC 2.59% · 1.31M sh
MAK Capital One, LLC 2.52% · 1.28M sh
First Eagle Investment Management, LLC 2.51% · 1.27M sh
Jerrell Shelton 2.37% · 1.20M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 21 sells

NameRoleStake
Jerrell Shelton Chairperson & CEO 2.37%
Robert Stefanovich Chief Financial Officer 0.22%
Edward Zecchini Independent Director 0.22%
Mark Sawicki Senior VP & Chief Scientific Officer 0.20%
Daniel Hancock Independent Director 0.14%
Linda Baddour Independent Director 0.13%
Robert Hariri Independent Director 0.12%
Ramkumar Mandalam Independent Director 0.11%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-10 Jerrell Shelton Chairperson & CEO Automatic Disposition -28,800 $14.91
2026-06-10 Edward Zecchini Independent Director Derivative Exercise and Sale -35,000 $4.80–15.23
2026-06-10 Edward Zecchini Independent Director Intent to Sell (Form 144) -33,600 $14.47
2026-06-09 Edward Zecchini Independent Director Intent to Sell (Form 144) -1,400 $15.23
2026-06-07 Ramkumar Mandalam Independent Director Open Market Disposition -23,214 $15.44
2026-06-04 Linda Baddour Independent Director Other Acquisition +10,350 --
2026-06-04 Linda Baddour Independent Director Other Derivative Acquisition +16,077 $15.70
2026-06-04 Robert Hariri Independent Director Other Acquisition +10,350 --
2026-06-04 Robert Hariri Independent Director Other Derivative Acquisition +16,077 $15.70
2026-06-04 Ramkumar Mandalam Independent Director Other Acquisition +10,350 --
2026-06-04 Ramkumar Mandalam Independent Director Other Derivative Acquisition +16,077 $15.70
2026-06-04 Daniel Hancock Independent Director Other Acquisition +10,350 --
2026-06-04 Daniel Hancock Independent Director Other Derivative Acquisition +16,077 $15.70
2026-06-03 Robert Stefanovich Chief Financial Officer Open Market Disposition -169,427 $16.27
2026-04-20 Jerrell Shelton Chairperson & CEO Derivative Exercise and Retained +104,007 $1.87
2026-04-05 Jerrell Shelton Chairperson & CEO Derivative Exercise and Retained +50,000 $1.87
2026-03-22 Robert Stefanovich Chief Financial Officer Open Market Disposition -1,094 $8.18
2026-03-22 Jerrell Shelton Chairperson & CEO Open Market Disposition -2,894 $8.18
2026-03-22 Jerrell Shelton Chairperson & CEO Derivative Exercise and Retained +25,000 $1.87
2026-03-22 Mark Sawicki Senior VP & Chief Scientific Officer Open Market Disposition -1,341 $8.18

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 09:16:57 · For reference only, not investment advice and not tailored to your situation.